Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA

Clinical Chemistry

Volumn 46, Issue 10, 2000, Pages 1610-1618

  Nurmikko, P ^a   Vaisanen, V ^a   Piironen, T ^a   Lindgren, S ^a   Lilja, H ^a   Pettersson, K ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME PRECURSOR; EPITOPE; LYSINE; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; TISSUE KALLIKREIN;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HYBRIDOMA; MALE; PEPTIDE MAPPING; PROSTATE ADENOCARCINOMA;

EID: 0033779889     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.10.1610     Document Type: Article

References (34)

1. Prostate antigen: A new potential marker for prostatic cancer
2. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
3. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
4. Serum prostate specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer
5. Molecular cloning of human prostate specific antigen cDNA
6. Primary structure of a human glandular kallikrein gene
7. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2
8. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2
9. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein
10. LNCaP model of human prostatic carcinoma
11. LNCaP produces both putative zymogen and inactive, free form of prostate-specific antigen
12. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCAP cells
13. A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum
14. Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer
15. Two-dimensional gel electrophoresis detects prostate-specific antigen-α(1)-antichymotrypsin complex in serum but not in prostatic fluid
16. Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity
17. Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen
18. Free and complexed prostate-specific antigen (PSA): In vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-α1-antichymotrypsin complex
19. Immunochemical analysis of antigenic determinants of Chlamydia trachomatis by monoclonal antibodies
20. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid
21. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling
22. The attractions of proteins for small molecules and ions
23. Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen
24. Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen
25. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors
26. α1-Antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia
27. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: Biochemical and diagnostic implications
28. A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue
29. Serum free prostate specific antigen: Isoenzymes in benign hyperplasia and cancer of the prostate
30. Nucleotide sequence of cloned cDNA for human pancreatic kallikrein
31. Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia
32. Human prostate-specific antigen: Structural and functional similarity with serine proteases
33. 'B-PSA', a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia
34. Prostate specific antigen in benign prostatic hyperplasia: Purification and characterization